Us Fda Approval
-
{
- All
- News
-
India's First Homegrown Antibiotic Zaynich Gets US FDA Approval; Here's What You Need To Know About The Drug
Zaynich is a novel injectable antibiotic developed to treat serious bacterial infections, especially complicated urinary tract infections. It is a combination of two components; cefepime, a fourth-generation cephalosporin antibiotic, and zidebactam, a new molecule developed by Wockhardt.
-
"Tea Is Healthy": India's Favourite Beverage Gets US FDA's Approval
The FDA announced a final rule updating the "healthy" nutrient content claim to help consumers identify foods that align with dietary recommendations.
-
Granules India Gets US FDA Nod For Tablets To Treat Major Depressive Disorder
The tablet that received the approval is therapeutically equivalent to Wellbutrin SR sustained-release tablets, 100 mg, 150 mg, and 200 mg, by GlaxoSmithKline LLC, an exchange filing said.
-
Granules India Gets US FDA Nod For Tablets To Treat Major Depressive Disorder
The tablet that received the approval is therapeutically equivalent to Wellbutrin SR sustained-release tablets, 100 mg, 150 mg, and 200 mg, by GlaxoSmithKline LLC, an exchange filing said.
-
Alembic Pharma Gets US FDA Nod For Generic Medication To Treat Seizure
Lamotrigine extended-release tablets have an estimated market size of $163 million, as per data for twelve months ending June 2024, according to IQVIA.
-
Zydus Life Gets Regulator Nod To Sell Post-Anaesthesia Drug In US
Scopolamine Transdermal System 1 mg/3 days has annual sales of $69.6 million in the United States.
-
Indoco Remedies Gets US FDA Approval For Opioids drug
Indoco will launch the product immediately in the US, where it is eligible for 180 days of competitive generic therapy exclusivity.
-
Alembic Pharma Gains After US FDA Gives Tentative Approval For Leukemia Medicines
The drug has an estimated market size of $275 million as of March, Alembic Pharma said, citing IQVIA, a consulting and information firm.
-
Dr Reddy's Laboratories Gets FDA Approval, Launches Drug In US Market
Dr Reddy's Laboratories on Wednesday said it has launched a vasopressin injection, which is used to control frequent urination, increased thirst, and loss of water caused by diabetes, in the American market.
-
Glenmark Pharma Gets USFDA Nod For Two Generic Drugs
Glenmark Pharma today said it has received final approval from the USFDA to manufacture and market Potassium Chloride extended release capsules and oral contraceptive Norethindrone Acetate and Ethinyl Estradiol tablets in the American market.
-
Glenmark Gets US Regulatory Nod for Contraceptive Drug
Glenmark Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for generic Ashlyna contraceptive tablets and launched them in the American market.
-
Cipla gets tentative US nod for HIV tablets
Cipla sells the combination drug under the brand name 'Duovir N' outside the United States.
-
India's First Homegrown Antibiotic Zaynich Gets US FDA Approval; Here's What You Need To Know About The Drug
Zaynich is a novel injectable antibiotic developed to treat serious bacterial infections, especially complicated urinary tract infections. It is a combination of two components; cefepime, a fourth-generation cephalosporin antibiotic, and zidebactam, a new molecule developed by Wockhardt.
-
"Tea Is Healthy": India's Favourite Beverage Gets US FDA's Approval
The FDA announced a final rule updating the "healthy" nutrient content claim to help consumers identify foods that align with dietary recommendations.
-
Granules India Gets US FDA Nod For Tablets To Treat Major Depressive Disorder
The tablet that received the approval is therapeutically equivalent to Wellbutrin SR sustained-release tablets, 100 mg, 150 mg, and 200 mg, by GlaxoSmithKline LLC, an exchange filing said.
-
Granules India Gets US FDA Nod For Tablets To Treat Major Depressive Disorder
The tablet that received the approval is therapeutically equivalent to Wellbutrin SR sustained-release tablets, 100 mg, 150 mg, and 200 mg, by GlaxoSmithKline LLC, an exchange filing said.
-
Alembic Pharma Gets US FDA Nod For Generic Medication To Treat Seizure
Lamotrigine extended-release tablets have an estimated market size of $163 million, as per data for twelve months ending June 2024, according to IQVIA.
-
Zydus Life Gets Regulator Nod To Sell Post-Anaesthesia Drug In US
Scopolamine Transdermal System 1 mg/3 days has annual sales of $69.6 million in the United States.
-
Indoco Remedies Gets US FDA Approval For Opioids drug
Indoco will launch the product immediately in the US, where it is eligible for 180 days of competitive generic therapy exclusivity.
-
Alembic Pharma Gains After US FDA Gives Tentative Approval For Leukemia Medicines
The drug has an estimated market size of $275 million as of March, Alembic Pharma said, citing IQVIA, a consulting and information firm.
-
Dr Reddy's Laboratories Gets FDA Approval, Launches Drug In US Market
Dr Reddy's Laboratories on Wednesday said it has launched a vasopressin injection, which is used to control frequent urination, increased thirst, and loss of water caused by diabetes, in the American market.
-
Glenmark Pharma Gets USFDA Nod For Two Generic Drugs
Glenmark Pharma today said it has received final approval from the USFDA to manufacture and market Potassium Chloride extended release capsules and oral contraceptive Norethindrone Acetate and Ethinyl Estradiol tablets in the American market.
-
Glenmark Gets US Regulatory Nod for Contraceptive Drug
Glenmark Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for generic Ashlyna contraceptive tablets and launched them in the American market.
-
Cipla gets tentative US nod for HIV tablets
Cipla sells the combination drug under the brand name 'Duovir N' outside the United States.
